Protalix Submits Validation Data on Manufacturing Process to FDA

CARMIEL, Israel, April 27 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA).  The Company made the submis

http://digg.com/u1Uaqi